![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C08L 71/02 | (2006.01) |
C08L 71/02 | (2013.01) | ||
C08G 65/332 | (2006.01) | ||
C08G 65/3322 | (2013.01) | ||
C08G 65/48 | (2006.01) | ||
C08G 65/48 | (2013.01) | ||
A61K 31/00 | (2006.01) | ||
A61K 31/7105 | (2013.01) | ||
A61K 31/7115 | (2013.01) | ||
A61K 9/5123 | (2013.01) | ||
A61K 47/14 | (2013.01) |
(11) | Number of the document | 3853305 |
(13) | Kind of document | T |
(96) | European patent application number | 19782825.4 |
Date of filing the European patent application | 2019-09-19 | |
(97) | Date of publication of the European application | 2021-07-28 |
(45) | Date of publication and mention of the grant of the patent | 2024-10-02 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2019/051906 |
Date | 2019-09-19 |
(87) | Number | WO 2020/061295 |
Date | 2020-03-26 |
(30) | Number | Date | Country code |
201862733456 P | 2018-09-19 | US | |
201862745164 P | 2018-10-12 | US |
(72) |
ALMARSSON, Örn , US
LIM, Jin , US
CHEUNG, Eugene , US
MILTON, Jaclyn , US
|
(73) |
ModernaTX, Inc. ,
325 Binney Street, Cambridge, MA 02142,
US
|
(54) | HIGH-PURITY PEG LIPIDS AND USES THEREOF |
HIGH-PURITY PEG LIPIDS AND USES THEREOF |